Mergenet Medical

Mergenet Medical was a medical device company specializing in the development of high-flow nasal oxygen (HFNO) therapy systems for patients with respiratory distress. Based in North Carolina, the company focused on creating more comfortable and efficient delivery mechanisms for non-invasive respiratory support. In April 2018, Mergenet Medical was acquired by Vapotherm, a prominent player in the respiratory care market, to bolster its intellectual property and product line in high-flow therapy. The acquisition allowed Vapotherm to integrate Mergenet's innovative cannula technology into its existing clinical solutions for hospitals and home care. The company's primary focus was on improving patient compliance and clinical outcomes in the treatment of chronic and acute breathing disorders.